Nonmyeloablative Bone Marrow Transplantation of BXSB Lupus Mice Using Fully Matched Allogeneic Donor Cells from Green Fluorescent Protein Transgenic Mice

Journal of Immunology

Volumn 172, Issue 9, 2004, Pages 5415-5419

  Jones, Olcay Y ^a,b   Steele, Ann ^a   Jones, Joe M ^a   Marikar, Yasmin ^a   Chang, Yenhui ^a   Feliz, Alexander ^a   Cahill, Richard A ^a,c   Good, Robert A ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b JOHNS HOPKINS ALL CHILDREN S HOSPITAL   (United States)

^c Cardinal Glennon Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD45 ANTIGEN; DOUBLE STRANDED DNA; GREEN FLUORESCENT PROTEIN;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; BONE MARROW; CHIMERA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLOMERULUS; MALE; MONOCYTOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; SYSTEMIC LUPUS ERYTHEMATOSUS; THYMUS; TRANSGENIC MOUSE;

EID: 2142659428     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.9.5415     Document Type: Article

References (37)

1. Andrews, B. S., R. A. Eisenberg, A. N. Theofilopoulos, S. Izui, C. B. Wilson, P. J. McConahey, E. D. Murphy, J. B. Roths, and F. J. Dixon. 1978. Spontaneous murine lupus-like syndromes: clinical and immunopathological manifestations in several strains. J. Exp. Med. 148:1198.
2. Klinman, D. M., and A. D. Steinberg. 1995. Inquiry into murine and human lupus. Immunol. Rev. 144:157.
3. Murphy, E. D., and J. B. Roths. 1979. A Y chromosome associated factor in strain BXSB producing accelerated autoimmunity and lymphoproliferation. Arthritis Rheum. 22:1188.
4. Fossati, L., M. Iwamoto, R. Merino, and S. Izui. 1995. Selective enhancing effect of the Yaa gene on immune responses against self and foreign antigens. Eur. J. Immunol. 25:166.
5. Theofilopoulos, A. N., P. J. McConahey, S. Izui, R. A. Eisenberg, A. B. Pereira, and W. D. Creighton. 1980. A comparative immunologic analysis of several murine strains with autoimmune manifestations. Clin. Immunol. Immunopathol. 15:258.
6. Wofsy, D., C. E. Kerger, and W. E. Seaman. 1984. Monocytosis in the BXSB model for systemic lupus erythematosus. J. Exp. Med. 159:629.
7. + T cells and homeostatic T cell proliferation in Y-chromosome-associated murine lupus. J. Immunol. 167:2354.
8. Ikehara, S., R. A. Good, T. Nakamura, K. Sekita, S. Inoue, M. M. Oo, E. Muso, K. Ogawa, and Y. Hamashima. 1985. Rationale for bone marrow transplantation in the treatment of autoimmune diseases. Proc. Natl. Acad. Sci. USA 82:2483.
9. Wang, B., Y. Yamamoto, N. S. El-Badri, and R. A. Good. 1999. Effective treatment of autoimmune disease and progressive renal disease by mixed bone-marrow transplantation that establishes a stable mixed chimerism in BXSB recipient mice. Proc. Natl. Acad. Sci. USA 96:3012.
10. Wang, B. Y., Cherry, N. S. El-Badri, and R. A. Good. 1997. Prevention of development of autoimmune disease in BXSB mice by mixed bone marrow transplantation. Proc. Natl. Acad. Sci. USA 94:12065.
11. Kawakami, N., N. Sakane, F. Nishizawa, M. Iwao, S. I. Fukada, K. Tsujikawa, Y. Kohama, M. Ikawa, M. Okabe, and H. Yamamoto. 1999. Green fluorescent protein-transgenic mice: immune functions and their application to studies of lymphocyte development. Immunol. Lett. 70:165.
12. Eisenberg, R. A., S. Izui, P. J. McConahey, L. Hang, C. J. Peters. A. N. Theofilopoulos, and F. J. Dixon. 1980. Male determined accelerated autoimmune disease in BXSB mice: transfer by bone marrow and spleen cells. J. Immunol. 125:1032.
13. Good, R. A. 2002. Cellular immunology in a historical perspective. Immunol. Rev. 185:136.
14. Ikehara, S., M. Kawamura, F. Takao, M. Inaba, R. Yasumizu, S. Than, H. Hisha, K. Sugiura, Y. Koide, T. O. Yoshida, et al. 1990. Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 87:8341.
15. Ikehara, S. 2001. Treatment of autoimmune diseases by hematopoietic stem cell transplantation. Exp. Hematol. 29:661.
16. Marmont, A. M. 1998. Stem cell transplantation for severe autoimmune diseases: progress and problems. Haematologica 83:733.
17. Van Bekkum, D. W. 1998. Autologous stem cell therapy for treatment of autoimmune diseases. Exp. Hematol. 26:831.
18. Petri, M., R. J. Jones, and R. A. Brodsky. 2003. High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus. Arthritis Rheum. 48:166.
19. Van Bekkum, D. W. 2002. Experimental basis of hematopoietic stem cell transplantation for treatment of autoimmune diseases. J. Leukocyte Biol. 72:609.
20. Chakrabarti, S., S. K. Handa, R. J. Bryon, M. J. Griffiths, and D. W. Milligan. 2001. Will mixed chimerism cure autoimmune diseases after a nonmyeloablative stem cell transplant? Transplantation 72:340.
21. Amrolia, P., H. B. Gaspar, A. Hassan, D. Webb, A. Jones, N. Sturt, G. Mieli-Vergani, A. Pagliuca, G. Mufti, N. Hadzic, et al. 2000. Nonmyeloablative stem cell transplantation for congenital immunodeficiencies. Blood 96:1239.
22. Mathieu, C., K. Casteels, R. Bouillon, and M. Waer. 1997. Protection against autoimmune diabetes in mixed bone marrow chimeras: mechanisms involved. J. Immunol. 158:1453.
23. Petz, L. D., P. Yam, R. B. Wallace, A. D. Stock, G. de Lange, R. G. Knowlton, V. A. Brown, H. Donis-Keller, L. R. Hill, S. J. Forman, et al. 1987. Mixed hematopoietic chimerism following bone marrow transplantation for hematologic malignancies. Blood 70:1331.
24. Slavin, S., A. Nagler, G. Varadi, and R. Or. 2000. Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis. Exp. Hematol. 28:853.
25. Sun, K. H., C. L. Yu, S. J. Tang, and G. H. Sun. 2000. Monoclonal anti-double-stranded DNA autoantibody stimulates the expression and release of IL-1β, IL-6, IL-8, IL-10 and TNF-α from normal human mononuclear cells involving in the lupus pathogenesis. Immunology 99:352.
26. Slavin, S., A. Nagler, E. Naparstek, Y. Kapelushnik, M. Aker, G. Cividalli, G. Varadi, M. Kirschbaum, A. Ackerstein, S. Samuel, et al. 1998. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 91:756.
27. Spitzer, T. R. 2000. Nonmyeloablative allogeneic stem cell transplant strategies and the role of mixed chimerism. Oncologist 5:215.
28. Seung, E., N. Iwakoshi, B. A. Woda, T. G. Markees, J. P. Mordes, A. A. Rossini, and D. L. Greiner. 2000. Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti-CD154 antibody: absence of graft-versus-host disease, induction of skin allograft tolerance, and prevention of recurrent autoimmunity in islet-allografted NOD/Lt mice. Blood 95:2175.
29. Wu, T., B. Levay-Young, N. Heuss, H. Sozen, N. Kirchhof, D. E. Sutherland, B. Hering, and Z. Guo. 2002. Inducing tolerance to MHC-matched allogeneic islet grafts in diabetic NOD mice by simultaneous islet and bone marrow transplantation under nonirradiative and nonmyeloablative conditioning therapy. Transplantation 74:22.
30. Leykin, I., B. Nikolic, and M. Sykes. 2001. Mixed bone marrow chimerism as a treatment for autoimmune diabetes. Transplant. Proc. 33:120.
31. Manilay, J. O., D. A. Pearson, J. J. Sergio, K. G. Swenson, and M. Sykes. 1998. Intrathymic deletion of alloreactive T cells in mixed bone marrow chimeras prepared with a nonmyeloablative conditioning regimen. Transplantation 66:96.
32. + cells in maintaining deletional tolerance in xenogeneic rat→mouse bone marrow chimeras. Transplantation 65:1216.
33. 1 hybrids. Immunology 100:99.
34. Vieten, G., M. R. Hadam, H. De Boer, A. Olp, M. Fricke, and K. Hartung. 1992. Expanded macrophage precursor populations in BXSB mice: possible reason for the increasing monocytosis in male mice. Clin. Immunol. Immunopathol. 65:212.
35. Imasawa, T., Y. Utsunomiya, T. Kawamura, Y. Zhong, R. Nagasawa, M. Okabe, N. Maruyama, T. Hosoya, and T. Ohno. 2001. The potential of bone marrow-derived cells to differentiate to glomerular mesangial cells. J. Am. Soc. Nephrol. 12:1401.
36. Jiang, Y., B. N. Jahagirdar, R. L. Reinhardt, R. E. Schwartz, C. D. Keene, X. R. Ortiz-Gonzalez, M. Reyes, T. Lenvik, T. Lund, M. Blackstad, et al. 2002. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41.
37. Yamada, M., H. Kubo, S. Kobayashi, K. Ishizawa, M. Numasaki, S. Ueda, T. Suzuki, and H. Sasaki. 2004. Bone marrow-derived progenitor cells are important for lung repair after lipopolysaccharide-induced lung injury. J. Immunol. 172:1266.